CN Patent

CN1946382B — 钙受体活性化合物的速溶制剂

Assigned to Amgen Inc · Expires 2010-12-08 · 15y expired

What this patent protects

本发明涉及包含治疗有效量的钙受体活性化合物与至少一种药学上可接受的载体的药用组合物，其中该组合物具有受控溶出曲线特性。本发明还涉及制备该药用组合物的方法以及用该组合物治疗疾病的方法。

USPTO Abstract

本发明涉及包含治疗有效量的钙受体活性化合物与至少一种药学上可接受的载体的药用组合物，其中该组合物具有受控溶出曲线特性。本发明还涉及制备该药用组合物的方法以及用该组合物治疗疾病的方法。

Drugs covered by this patent

cinacalcet-hydrochloride (CINACALCET HYDROCHLORIDE)

Patent Metadata

Patent number: CN1946382B
Jurisdiction: CN
Classification: —
Expires: 2010-12-08
Drug substance claim: No
Drug product claim: No
Assignee: Amgen Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.